In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Lemonade (LMND – Research Report), with a price target of $17.00. The company’s shares closed yesterday at $21.72.
According to TipRanks, Kligerman is a 5-star analyst with an average return of 19.8% and a 70.83% success rate. Kligerman covers the Financial sector, focusing on stocks such as Chubb, Allstate, and Aon.
In addition to TD Cowen, Lemonade also received a Hold from KBW’s Thomas McJoynt Griffith in a report issued yesterday. However, today, Morgan Stanley reiterated a Sell rating on Lemonade (NYSE: LMND).
See the top stocks recommended by analysts >>
LMND market cap is currently $1.25B and has a P/E ratio of -5.39.
Based on the recent corporate insider activity of 17 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of LMND in relation to earlier this year. Last month, John Sheldon Peters, the Chief Insurance Officer of LMND bought 10,000.00 shares for a total of $26,500.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Lemonade (LMND) Company Description:
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read More on LMND:
- LMND Earnings: Lemonade Drops As Q1 Forecast Disappoints
- Lemonade Inc. Releases Q4 Supplementary Shareholder Information
- Lemonade Inc (LMND) Q4 Earnings Cheat Sheet
- Short Report: Bears boost WW exposure ahead of earnings after marketing debacle
- Lemonade call volume above normal and directionally bullish
